JOINT FILING AGREEMENTJoint Filing Agreement • April 4th, 2018 • Iroquois Capital Management, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001 per share, of TapImmune, Inc., a Nevada corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
